Key result
Emergency immunization limits future paralytic polio cases to <1 following sustained New York transmission.
Why the study?
In July 2022, New York State reported a case of paralytic polio in an unvaccinated adult, with wastewater surveillance confirming sustained local transmission of type 2 vaccine-derived poliovirus.
Imported polioviruses may circulate and pose a small but nonzero risk of causing paralysis in nonimmune individuals even in countries with high average immunization coverage using inactivated poliovirus vaccine.
Minimal paralysis risk despite VDPV2 transmission; leaves open optimal surveillance intensity in high-IPV coverage settings.
BACKGROUND: In July 2022, New York State (NYS) reported a case of paralytic polio in an unvaccinated young adult, and subsequent wastewater surveillance confirmed sustained local transmission of type 2 vaccine-derived poliovirus (VDPV2) in NYS with genetic linkage to the paralyzed patient. METHODS: We adapted an established poliovirus transmission and oral poliovirus vaccine evolution model to characterize dynamics of poliovirus transmission in NYS, including consideration of the immunization activities performed as part of the declared state of emergency. RESULTS: Despite sustained transmission of imported VDPV2 in NYS involving potentially thousands of individuals (depending on seasonality, population structure, and mixing assumptions) in 2022, the expected number of additional paralytic cases in years 2023 and beyond is small (less than 0.5). However, continued transmission and/or reintroduction of poliovirus into NYS and other populations remains a possible risk in communities that do not achieve and maintain high immunization coverage. CONCLUSIONS: In countries such as the United States that use only inactivated poliovirus vaccine, even with high average immunization coverage, imported polioviruses may circulate and pose a small but nonzero risk of causing paralysis in nonimmune individuals.
No takes yet. Share an insight, caveat, or question.
Thompson et al. (2023) studied Poliovirus transmission. Imported type 2 vaccine-derived poliovirus (cVDPV2) was evaluated on Expected number of additional paralytic cases in years 2023 and beyond. Despite sustained transmission of imported type 2 vaccine-derived poliovirus in New York State in 2022 involving thousands of individuals, the expected number of additional paralytic cases in 2023 and beyond is less than 0.5.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: